相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysis
Toshifumi Tada et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis et al.
CANCERS (2021)
Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice
Hideki Iwamoto et al.
CANCERS (2021)
Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study
Yen-Yang Chen et al.
CANCERS (2021)
Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
Liwei Ni et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment
Shasha Sun et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2020)
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
Toshifumi Tada et al.
LIVER INTERNATIONAL (2020)
Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis
Lixing Liu et al.
FRONTIERS IN ONCOLOGY (2020)
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE
Isabel Theresa Schobert et al.
EUROPEAN RADIOLOGY (2020)
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy
Sirish Dharmapuri et al.
CANCER MEDICINE (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis
Wang Gu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review
Ayman Bannaga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp et al.
BMC MEDICINE (2020)
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
Yen-Yang Chen et al.
PEERJ (2020)
The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
Chaobin He et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis
Atsushi Hiraoka et al.
CANCER MEDICINE (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with ovarian cancer A systematic review and meta-analysis
Xinming Yin et al.
MEDICINE (2019)
Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
Dong Wang et al.
PEERJ (2019)
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
Atsushi Hiraoka et al.
CANCER MEDICINE (2019)
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
Priti S. Hegde et al.
SEMINARS IN CANCER BIOLOGY (2018)
Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma
Kai Chen et al.
ONCOLOGY LETTERS (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis
Chia-Che Wu et al.
PEERJ (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection
Tianbo Yang et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
Nicola Personeni et al.
ONCOTARGET (2017)
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review
Jun Zheng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
Josee-Lyne Ethier et al.
BREAST CANCER RESEARCH (2017)
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review
Michele Marchioni et al.
CLINICAL GENITOURINARY CANCER (2016)
Prognostic prediction of male recipients selected for liver transplantation: With special attention to neutrophil to lymphocyte ratio
Wei Wang et al.
HEPATOLOGY RESEARCH (2016)
Neutrophilulymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: A systematic review and meta-analysis
Po-Li Tsai et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
Jeffrey J. Wallin et al.
NATURE COMMUNICATIONS (2016)
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study
S. Iwamoto et al.
ANNALS OF ONCOLOGY (2015)
Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysis
Jian-Jun Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
Weiliang Xia et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
A Systematic Review of Sorafenib in Child-Pugh A Patients With Unresectable Hepatocellular Carcinoma
Ai Shen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer
MS Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
